Traws Pharma
TRAW
TRAW
16 hedge funds and large institutions have $5.97M invested in Traws Pharma in 2018 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 0 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
74% less capital invested
Capital invested by funds: $22.5M → $5.97M (-$16.6M)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 5
Holders
16
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$101K | |
| 2 | +$32K | |
| 3 | +$30K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$29K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$28K |
Top Sellers
| 1 | -$207K | |
| 2 | -$174K | |
| 3 | -$161K | |
| 4 |
KC
Kepos Capital
New York
|
-$151K |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$49K |